EXE-T1D - EXtremely Early-onset Type 1 Diabetes
Research type
Research Study
Full title
Understanding beta-cell destruction through the study of EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum study)
IRAS ID
228082
Contact name
Richard Oram
Contact email
Sponsor organisation
University of Exeter
Duration of Study in the UK
3 years, 5 months, 28 days
Research summary
A study to assess clinical phenotype, beta cell function, genetics, and autoantibodies in Extremely Early Type 1 Diabetes (EET1D) to better understand the aetiology and progression of beta cell destruction in Type 1 diabetes (T1D) occurring in the first year of life.
As a study of a very rare disease (<100 in UK) defined by genetics, it is adopted as a Musketeers' Memorandum Study.
REC name
East Midlands - Derby Research Ethics Committee
REC reference
17/EM/0255
Date of REC Opinion
28 Jul 2017
REC opinion
Further Information Favourable Opinion